KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Assets Average (2018 - 2025)

Historic Assets Average for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $640.0 million.

  • Twist Bioscience's Assets Average rose 466.46% to $640.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $640.0 million, marking a year-over-year increase of 466.46%. This contributed to the annual value of $628.1 million for FY2025, which is 967.42% down from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's Assets Average is $640.0 million, which was up 466.46% from $642.7 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Assets Average registered a high of $1.0 billion during Q2 2022, and its lowest value of $602.1 million during Q1 2025.
  • For the 5-year period, Twist Bioscience's Assets Average averaged around $752.5 million, with its median value being $715.8 million (2021).
  • In the last 5 years, Twist Bioscience's Assets Average skyrocketed by 16675.61% in 2021 and then crashed by 2106.8% in 2024.
  • Quarter analysis of 5 years shows Twist Bioscience's Assets Average stood at $744.1 million in 2021, then increased by 25.74% to $935.7 million in 2022, then decreased by 19.35% to $754.6 million in 2023, then dropped by 18.97% to $611.5 million in 2024, then increased by 4.66% to $640.0 million in 2025.
  • Its Assets Average stands at $640.0 million for Q4 2025, versus $642.7 million for Q3 2025 and $619.6 million for Q2 2025.